Search

everythinglearnresearchcommunity

for

Search:↓

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

High CRP levels could indicate vitamin D deficiency in people with alopecia areata.

RCS-01 is safe and may help rejuvenate aging skin.

Timely treatment of eosinophilic asthma in rheumatic disease patients can prevent organ damage.

Asthma may increase the risk of alopecia areata.

Two patients with stubborn hair loss grew hair after PDRN injections.

Enhancing Tregs can protect against alopecia areata.

β-catenin in the dermal papilla is crucial for normal hair growth and repair.

Adding stem cells to fat grafts for facial rejuvenation might improve outcomes, but more research is needed to confirm safety and effectiveness.

MPA increases cancer spread by boosting Eph A2 activity.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

IL-4 and IL-13 might play a role in a type of hair loss similar to alopecia areata.

Human placenta extract reduces inflammation and symptoms in atopic dermatitis.

Tralokinumab effectively improved atopic dermatitis symptoms in most patients, but some stopped due to side effects like hair loss.

A new model uses specific blood markers to predict if children's hair loss will return.

A new method helps diagnose alopecia areata using specific gene markers and could guide targeted treatments.

Topical immunotherapy is the best treatment for severe alopecia areata.

Atopic dermatitis may trigger alopecia areata, and early treatment can help prevent severe cases.

A 5-year-old boy's seasonal hair loss is linked to his allergies.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

The new cream is safe and effective for mild to moderate atopic dermatitis.

Using a strong allergy medicine too often on the scalp can cause swelling and inflammation.

A parasite molecule can speed up skin healing and reduce scarring.

The study found a specific peptide that helps detect TGase 3 activity in skin and hair follicles.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

Ruxolitinib helped a patient with alopecia areata regrow hair.

Autologous micrografting via the Rigenera® system shows promise in improving hair loss treatment.

Upadacitinib improved symptoms and hair regrowth in a teen with multiple autoimmune conditions.

The Enriched-GF method efficiently produces high-yield growth factors for tissue repair.